Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts.
Bizhong CheChongke ZhongJigang DuMengyuan MiaoMengyao ShiYanbo PengPinni YangDaoxia GuoJing ChenAili WangTan XuYonghong ZhangJiang HePublished in: European journal of neurology (2023)
Both CCL19 and CCL21 levels were independently associated with adverse outcomes within 3 months after ischemic stroke and should be further investigated for risk stratification and potential therapeutic targets of ischemic stroke.